Sign In
Buy TOMDF
$0.000001
+0 (+0%)
At Close: Jun 02, 2026
Todos Medical pursuing New York Stock Exchange listing, it says in a wide-ranging update into new business developments
12:51pm, Tuesday, 11'th Oct 2022
Todos Medical Ltd told investors it was seeking a New York Stock Exchange listing and revealed it is in the final stages of launching a crowdfunding campaign for its subsidiary 3CL Pharma and its Long
Todos Medical Provides Corporate Update
11:30am, Tuesday, 11'th Oct 2022
3CL Pharma prepares to crowdfund for Long COVID trials of Tollovir™ and Tollovid™ CEO to Present at Emerging Growth Conference on Wednesday, October 12, 2022 at 2pm ET New York, NY, and Tel Aviv,
Todos Medical touts successful pilot launch of suite of PCR testing services by its lab Provista Diagnostics
10:44am, Thursday, 06'th Oct 2022
Todos Medical Ltd revealed that its CLIA/CAP accredited lab Provista Diagnostics has successfully completed a pilot launch of a suite of polymerase chain reaction (PCR) testing services in the rural c
Todos Medical set to be granted two patents for its TBIA pan-cancer blood diagnostics platform
11:46am, Friday, 30'th Sep 2022
Todos Medical Ltd has welcomed news it will be granted two patents covering its total biochemical infrared analysis (TBIA) fourier transformed infrared (FTIR) pan-cancer blood diagnostics platform. Th
Todos Medical announces receipt of notice of allowance for its 3CL protease biomarker diagnostics TolloTest
12:54pm, Tuesday, 27'th Sep 2022
Todos Medical Ltd said its majority-owned joint venture 3CL Pharma Ltd has received a notice of allowance issued by the US patent and trademark office for its TolloTest. The test is designed to dete
Todos Medical strikes $50M contact with Nerd Hemp to distribute Tollovid and CBD products in AI retail machines across the US
05:08pm, Thursday, 22'nd Sep 2022
Todos Medical Ltd announced it has signed a contract worth $50 million with CBD retail distributor Nerd Hemp Inc to supply its lead product Tollovid and botanical '0% THC' CBD products in pill, tinctu
Todos Medical announces NFL Hall of Famer Michael Irvin as Tollovid Sports Ambassador for #TolloUp campaign
08:27am, Friday, 16'th Sep 2022
Todos Medical Ltd. (OTCQB:TOMDF) has announced that Michael Irvin has agreed to become the Sports Ambassador for its majority-owned subsidiary 3CL Pharma's #TolloUp marketing campaign for the 3CL prot
Todos Medical initiates validation plan for PCR-based polio testing at its Provista Diagnostics laboratory
09:35am, Wednesday, 14'th Sep 2022
Todos Medical Ltd. announced that its CLIA/CAP-certified laboratory Provista Diagnostics has initiated a validation plan for PCR-based polio testing.
Todos Medical partner NLC Pharma assigns IP for Tollovir, Tollovid, and TolloTest to joint venture 3CL Pharma
10:35am, Monday, 12'th Sep 2022
Todos Medical Ltd. (OTCQB:TOMDF) said it has signed an amendment to its agreement with its 3CL protease biology theranostics partner NLC Pharma Ltd, with the latter assigning ownership of all relevant
Todos Medical inks lease deal on botanical supplement manufacturing facility in Texas to produce Tollovid
10:27am, Wednesday, 31'st Aug 2022
Todos Medical Ltd said it has entered into a lease agreement for a 15,200-square-foot botanical supplement manufacturing facility on a 6-acre lot located in the Dallas-Fort Worth area of Texas. The
Todos Medical expands COVID onsite school sample collection to include MonkeyPox
09:53am, Monday, 29'th Aug 2022
Todos Medical Ltd. (OTCQB:TOMDF) has said its Atlanta-area clinical laboratory, Provista Diagnostics Inc, is expanding its onsite school sample collection programs for COVID-19 PCR testing to include
Todos Medical Ltd has announced that it's Atlanta-area CLIA/CAP-certified clinical laboratory Provista Diagnostics Inc is now offering saliva-only MonkeyPox testing. The company said the saliva-ba
Todos Medical reports rise in 2Q revenue, initiates Monkeypox diagnostic case study series
09:58am, Tuesday, 23'rd Aug 2022
Todos Medical Ltd. (OTCQB:TOMDF) has reported its financial results for the second quarter of 2022 ended June 30, 2022, showing an increase in revenue to $2.18 million, compared to $1.73 million in
Todos Medical reports rise in 2Q revenue
07:44am, Tuesday, 23'rd Aug 2022
Todos Medical Ltd. (OTCQB:TOMDF) has reported its financial results for the second quarter of 2022 ended June 30, 2022, showing an increase in revenue to $2.18 million, compared to $1.73 million in
NEW YORK, NY, and TEL AVIV, ISRAEL, Aug. 22, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today
